Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® ...
MarketBeat on MSN
Seer Q1 earnings call highlights
Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing ...
Seer, Inc. ( SEER) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT Good day, and welcome to Seer First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being ...
Hi. My name is Yuko Oku and I'm part of the life science tools and diagnostics team at Morgan Stanley. Before we begin, I'd like to remind our listeners that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results